• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫功能低下个体长期感染中的病毒进化

Virus Evolution in Prolonged Infections of Immunocompromised Individuals.

作者信息

Raglow Zoe, Lauring Adam S

机构信息

Division of Infectious Diseases, Department of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.

Department of Microbiology and Immunology, University of Michigan, Ann Arbor, MI, United States.

出版信息

Clin Chem. 2025 Jan 3;71(1):109-118. doi: 10.1093/clinchem/hvae150.

DOI:10.1093/clinchem/hvae150
PMID:39749520
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11822857/
Abstract

BACKGROUND

Many viruses can cause persistent infection and/or viral shedding in immunocompromised hosts. This is a well-described occurrence not only with SARS-CoV-2 but for many other viruses as well. Understanding how viruses evolve and mutate in these patients and the global impact of this phenomenon is critical as the immunocompromised population expands.

CONTENT

In this review, we provide an overview of populations at risk for prolonged viral shedding, clinical manifestations of persistent viral infection, and methods of assessing viral evolution. We then review the literature on viral evolution in immunocompromised patients across an array of RNA viruses, including SARS-CoV-2, norovirus, influenza, and poliovirus, and discuss the global implications of persistent viral infections in these hosts.

SUMMARY

There is significant evidence for accelerated viral evolution and accumulation of mutations in antigenic sites in immunocompromised hosts across many viral pathogens. However, the implications of this phenomenon are not clear; while there are rare reports of transmission of these variants, they have not clearly been shown to predict disease outbreaks or have significant global relevance. Emerging methods including wastewater monitoring may provide a more sophisticated understanding of the impact of variants that evolve in immunocompromised hosts on the wider host population.

摘要

背景

许多病毒可在免疫功能低下的宿主中引起持续感染和/或病毒脱落。这不仅是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的常见现象,许多其他病毒也如此。随着免疫功能低下人群的增加,了解病毒在这些患者体内如何进化和变异以及这一现象的全球影响至关重要。

内容

在本综述中,我们概述了病毒长期脱落的高危人群、持续性病毒感染的临床表现以及评估病毒进化的方法。然后,我们回顾了一系列RNA病毒(包括SARS-CoV-2、诺如病毒、流感病毒和脊髓灰质炎病毒)在免疫功能低下患者中病毒进化的文献,并讨论了这些宿主中持续性病毒感染的全球影响。

总结

有大量证据表明,在许多病毒病原体的免疫功能低下宿主中,病毒进化加速,抗原位点突变积累。然而,这一现象的影响尚不清楚;虽然有这些变异株传播的罕见报道,但它们尚未明确显示能预测疾病暴发或具有重大全球相关性。包括废水监测在内的新兴方法可能会让我们更深入地了解免疫功能低下宿主中进化的变异株对更广泛宿主群体的影响。

相似文献

1
Virus Evolution in Prolonged Infections of Immunocompromised Individuals.免疫功能低下个体长期感染中的病毒进化
Clin Chem. 2025 Jan 3;71(1):109-118. doi: 10.1093/clinchem/hvae150.
2
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
3
Physical interventions to interrupt or reduce the spread of respiratory viruses.物理干预措施以阻断或减少呼吸道病毒的传播。
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
6
Virological Aspects of COVID-19 in Patients with Hematological Malignancies: Duration of Viral Shedding and Genetic Analysis.血液系统恶性肿瘤患者中 COVID-19 的病毒学特征:病毒脱落持续时间及基因分析
Viruses. 2024 Dec 31;17(1):46. doi: 10.3390/v17010046.
7
NIH Consensus Statement on Management of Hepatitis C: 2002.美国国立卫生研究院关于丙型肝炎管理的共识声明:2002年。
NIH Consens State Sci Statements. 2002;19(3):1-46.
8
Determinants of susceptibility to SARS-CoV-2 infection in murine ACE2.小鼠血管紧张素转换酶2(ACE2)对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染易感性的决定因素。
J Virol. 2025 Jun 17;99(6):e0054325. doi: 10.1128/jvi.00543-25. Epub 2025 May 12.
9
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.用于治疗 COVID-19 的 SARS-CoV-2 中和单克隆抗体。
Cochrane Database Syst Rev. 2021 Sep 2;9(9):CD013825. doi: 10.1002/14651858.CD013825.pub2.
10
The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.样本采集部位和采集程序对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染鉴定的影响。
Cochrane Database Syst Rev. 2024 Dec 16;12(12):CD014780. doi: 10.1002/14651858.CD014780.

本文引用的文献

1
Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage.追踪在城市污水流域中检测到的 SARS-CoV-2 奥密克戎样刺突序列的起源:对隐匿性污水谱系进行的靶向、纵向监测研究。
Lancet Microbe. 2024 Apr;5(4):e335-e344. doi: 10.1016/S2666-5247(23)00372-5. Epub 2024 Mar 11.
2
Prevalence of Immunosuppression Among US Adults.美国成年人中免疫抑制的患病率。
JAMA. 2024 Mar 12;331(10):880-882. doi: 10.1001/jama.2023.28019.
3
SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis.奥密克戎时期免疫功能低下患者的新冠病毒脱落与演变:一项多中心前瞻性分析
Lancet Microbe. 2024 Mar;5(3):e235-e246. doi: 10.1016/S2666-5247(23)00336-1. Epub 2024 Jan 26.
4
SARS-CoV-2 viral clearance and evolution varies by type and severity of immunodeficiency.SARS-CoV-2 病毒清除和演变因免疫缺陷的类型和严重程度而异。
Sci Transl Med. 2024 Jan 24;16(731):eadk1599. doi: 10.1126/scitranslmed.adk1599.
5
Analysis of SARS-CoV-2 genome evolutionary patterns.分析 SARS-CoV-2 基因组的进化模式。
Microbiol Spectr. 2024 Feb 6;12(2):e0265423. doi: 10.1128/spectrum.02654-23. Epub 2024 Jan 10.
6
Sequential intrahost evolution and onward transmission of SARS-CoV-2 variants.新冠病毒变异株在宿主内的连续进化和传播。
Nat Commun. 2023 Jun 3;14(1):3235. doi: 10.1038/s41467-023-38867-x.
7
Factors affecting prolonged SARS-CoV-2 infection and development and validation of predictive nomograms.影响 SARS-CoV-2 感染延长的因素及预测列线图的建立和验证。
J Med Virol. 2023 Feb;95(2):e28550. doi: 10.1002/jmv.28550.
8
Post-Transplant Lymphoproliferative Disease (PTLD) after Allogeneic Hematopoietic Stem Cell Transplantation: Biology and Treatment Options.异基因造血干细胞移植后的移植后淋巴细胞增殖性疾病(PTLD):生物学特性与治疗选择
J Clin Med. 2022 Dec 19;11(24):7542. doi: 10.3390/jcm11247542.
9
The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK.英国新冠病毒B.1.1.7谱系的起源与分子进化
Virus Evol. 2022 Aug 26;8(2):veac080. doi: 10.1093/ve/veac080. eCollection 2022.
10
Long-term SARS-CoV-2 Asymptomatic Carriage in an Immunocompromised Host: Clinical, Immunological, and Virological Implications.免疫功能低下宿主中 SARS-CoV-2 的长期无症状携带:临床、免疫学和病毒学意义。
J Clin Immunol. 2022 Oct;42(7):1371-1378. doi: 10.1007/s10875-022-01313-6. Epub 2022 Jul 2.